Epstein Secrets

8 1759 COC(H/H BBC NBC PLT)( ) ( )8 478 CEA ( )8 334 muumuu:rum ( ) 374 CV, TOTAL ( ) 10231 COMP META PHL ) 167' CORTISOL, TOTAL 4 )8 10124 HS CRP ( ) 859 13, TOTAL ( ) 375 CREATININE ( ) 549 IMBUNOFIXATIOR,S£RUM ( )8 867 14 (THYROXINE) i ( y" 4420 CRP ( )8 571 IRON, TOTAL ( )8 866 14

no NEST ( ) 10019 861 T3 UPTAKE ) 30264 TESTOSTERONE,MALE TRIGLYCERIDES TSH UREA NITROGEN (DU URIC ACID URINALYSIS MACRO URINALYSIS REFLEX. URINALYSIS, CIMPL VII 8,25-ini,Toint VITAMIN 012 CULTURE, THROAT CULTURE, UR ROM FECAL InnunocnEn FECAL INDUNOCHEM OVA AND PARASITE SAIM/SHIG, COLIMA S

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

ILS ABSOLUTE LYMPHOCYTES ABSOLUTE MONOCYTES ABSOLUTE EOSINOPHILS ABSOLUTE BASOPHILS NEUTROPHILS LYMPHOCYTES MONOCYTES EOSINOPHILS BASOPHILS URINALYSIS, COMPLETE See Endnote 2 VITAMIN B12 In Range 9 Out Of Range Reference Range < OR = 20 mm/h 5.9 3.8-10.8 Thousand/uL 5.12 4.20-5.80 Million

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 0.9 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

ILS ABSOLUTE LYMPHOCYTES ABSOLUTE MONOCYTES ABSOLUTE EOSINOPHILS ABSOLUTE BASOPHILS NEUTROPHILS LYMPHOCYTES MONOCYTES EOSINOPHILS BASOPHILS URINALYSIS, COMPLETE See Endnote 2 VITAMIN B12 In Range 9.7 2582 2177 502 371 68 45.3 38.2 8.8 6.5 1.2 Out Of Range Reference Range 7.5-12.5 fL

heart disease. CHOL/HDLC RATIO 8.4 H NON HDL CHOLESTEROL 186 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.8 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

ILS ABSOLUTE LYMPHOCYTES ABSOLUTE MONOCYTES ABSOLUTE EOSINOPHILS ABSOLUTE BASOPHILS NEUTROPHILS LYMPHOCYTES MONOCYTES EOSINOPHILS BASOPHILS URINALYSIS, COMPLETE See Endnote 2 In Range 9.7 2664 2304 510 450 72 44.4 38.4 8.5 7.5 1.2 Out Of Range Reference Range 7.5-12.5 fL 1500-7800 c

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

YTES 454 ABSOLUTE EOSINOPHILS 390 ABSOLUTE BASOPHILS 38 NEUTROPHILS 51.5 LYMPHOCYTES 34.7 MONOCYTES 7.1 EOSINOPHILS 6.1 BASOPHILS 0.6 URINALYSIS, COMPLETE COLOR YELLOW APPEARANCE CLEAR SPECIFIC GRAVITY 1.023 PH < OR 5.0 GLUCOSE NEGATIVE BILIRUBIN NEGATIVE KETONES NEGATIVE OCCUL

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

ILS ABSOLUTE LYMPHOCYTES ABSOLUTE MONOCYTES ABSOLUTE EOSINOPHILS ABSOLUTE BASOPHILS NEUTROPHILS LYMPHOCYTES MONOCYTES EOSINOPHILS BASOPHILS URINALYSIS, COMPLETE COLOR APPEARANCE SPECIFIC GRAVITY PH GLUCOSE BILIRUBIN KETONES OCCULT BLOOD PROTEIN NITRITE LEUKOCYTE ESTERASE WBC RBC SQUAMO

ith diabetes plus I major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/c1L) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to MIA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

443 15-500 colls/uL ABSOLUTE BASOPHILS 59 0-200 cells/uL NEUTROPHILS 48.8 LYMPHOCYTES 34.2 MONOCYTES 8.5 EOSINOPHILS 7.5 BASOPHILS 1.0 URINALYSIS, COMPLETE MI See Sndnote VITAMIN 612 371 200-1100 pg/m1 M1 Please Note: Although the reference range for vitamin B12 is 200-1100 pg/mL, it ha

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

YTES 454 ABSOLUTE EOSINOPHILS 390 ABSOLUTE BASOPHILS 38 NEUTROPHILS 51.5 LYMPHOCYTES 34.7 MONOCYTES 7.1 EOSINOPHILS 6.1 BASOPHILS 0.6 URINALYSIS, COMPLETE COLOR YELLOW APPEARANCE CLEAR SPECIFIC GRAVITY 1.023 PH < OR 5.0 GLUCOSE NEGATIVE BILIRUBIN NEGATIVE KETONES NEGATIVE OCCUL